MAMIVAC
MAMIVAC
Suspended
- Staphylococcus aureus, strain 74240, Inactivated
Product identification
Medicine name:
MAMIVAC
Active substance:
- Staphylococcus aureus, strain 74240, Inactivated
Target species:
-
Sheep
-
Goat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Staphylococcus aureus, strain 74240, Inactivated40.00/80% effective dose in rabbit2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Sheep
-
Meat and offal0day
-
Milk0day
-
-
Goat
-
Meat and offal0day
-
Milk0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI04AB10
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Suspended
Authorised in:
-
Romania
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
- Pasteur Filiala Filipesti S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Pasteur Filiala Filipesti S.A.
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 160403
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Romanian (PDF)
Published on: 24/05/2022